Endocrineversus endocrine plus five-drug chemotherapy in postmenopausal women with stage II estrogen receptor-positive breast cancer
- 1 November 1989
- Vol. 64 (9), 1819-1823
- https://doi.org/10.1002/1097-0142(19891101)64:9<1819::aid-cncr2820640910>3.0.co;2-n
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Prolonging Tamoxifen Therapy for Primary Breast CancerAnnals of Internal Medicine, 1987
- Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancerBreast Cancer Research and Treatment, 1985
- Progesterone Receptors as a Prognostic Factor in Stage II Breast CancerNew England Journal of Medicine, 1983
- Likelihood Methods and Nonparametric TestsJournal of the American Statistical Association, 1978
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examplesBritish Journal of Cancer, 1977
- Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and designBritish Journal of Cancer, 1976
- IMPROVED SENSITIVITY: IN THE MEASUREMENT OF ESTROGEN RECEPTOR IN HUMAN BREAST CANCERJournal of Clinical Endocrinology & Metabolism, 1973